Compared to healthy adults, SYT13 gene expression is downregulated in T2DM patients, and downregulation of this gene decreases islet secretory function and is negatively associated with HbA1c levels in vivo (32). This evidence concerns the gene SYT13 and type 2 diabetes mellitus.